<DOC>
	<DOCNO>NCT00266006</DOCNO>
	<brief_summary>This trial conduct Japan . The purpose trial evaluate safety preliminary efficacy Activated Recombinant Factor VII ( NN-007 ) patient acute intracerebral haemorrhage .</brief_summary>
	<brief_title>Factor VIIa Acute Intracerebral Haemorrhage</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Cerebral Hemorrhage</mesh_term>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<criteria>Spontaneous ICH Time ICH onset &gt; 3 hour Patients secondary ICH Preexisting disability Hemophilia</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>